Nuwellis, Inc. (NUWE)
USD 0.96
(-4.0%)
USD 0.96
(-4.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 22.61 Million USD | 3.13% |
| 2022 | 21.92 Million USD | -8.71% |
| 2021 | 24.01 Million USD | 13.91% |
| 2020 | 21.08 Million USD | 0.61% |
| 2019 | 20.95 Million USD | 14.12% |
| 2018 | 18.36 Million USD | 57.62% |
| 2017 | 11.65 Million USD | -28.25% |
| 2016 | 16.23 Million USD | -37.59% |
| 2015 | 26.01 Million USD | -0.25% |
| 2014 | 26.08 Million USD | 13.75% |
| 2013 | 22.93 Million USD | 54.21% |
| 2012 | 14.86 Million USD | -10.22% |
| 2011 | 16.56 Million USD | 150.2% |
| 2010 | 6.61 Million USD | -3.54% |
| 2009 | 6.86 Million USD | -29.54% |
| 2008 | 9.73 Million USD | -22.21% |
| 2007 | 12.51 Million USD | 87.17% |
| 2006 | 6.68 Million USD | 60.22% |
| 2005 | 4.17 Million USD | 241.29% |
| 2004 | 1.22 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 3.79 Million USD | -36.13% |
| 2024 Q1 | 5.94 Million USD | 19.25% |
| 2023 Q4 | 4.98 Million USD | 9.59% |
| 2023 Q3 | 4.54 Million USD | -26.33% |
| 2023 FY | 22.61 Million USD | 3.13% |
| 2023 Q1 | 6.91 Million USD | 17.95% |
| 2023 Q2 | 6.16 Million USD | -10.83% |
| 2022 Q1 | 5.51 Million USD | 5.61% |
| 2022 Q2 | 5.36 Million USD | -2.79% |
| 2022 FY | 21.92 Million USD | -8.71% |
| 2022 Q4 | 5.86 Million USD | 13.25% |
| 2022 Q3 | 5.17 Million USD | -3.45% |
| 2021 Q3 | 6.37 Million USD | 2.15% |
| 2021 FY | 24.01 Million USD | 13.91% |
| 2021 Q2 | 6.23 Million USD | 0.86% |
| 2021 Q1 | 6.18 Million USD | 13.86% |
| 2021 Q4 | 5.22 Million USD | -17.99% |
| 2020 FY | 21.08 Million USD | 0.61% |
| 2020 Q1 | 5.4 Million USD | 5.08% |
| 2020 Q2 | 5.11 Million USD | -5.22% |
| 2020 Q3 | 5.13 Million USD | 0.31% |
| 2020 Q4 | 5.43 Million USD | 5.76% |
| 2019 Q2 | 5.27 Million USD | -1.09% |
| 2019 Q1 | 5.32 Million USD | 11.74% |
| 2019 FY | 20.95 Million USD | 14.12% |
| 2019 Q4 | 5.14 Million USD | -1.51% |
| 2019 Q3 | 5.21 Million USD | -0.97% |
| 2018 Q4 | 4.76 Million USD | 1.49% |
| 2018 Q3 | 4.69 Million USD | 6.58% |
| 2018 Q2 | 4.4 Million USD | -1.83% |
| 2018 Q1 | 4.49 Million USD | 41.6% |
| 2018 FY | 18.36 Million USD | 57.62% |
| 2017 FY | 11.65 Million USD | -28.25% |
| 2017 Q4 | 3.17 Million USD | 4.38% |
| 2017 Q3 | 3.03 Million USD | 10.59% |
| 2017 Q2 | 2.74 Million USD | 1.93% |
| 2017 Q1 | 2.69 Million USD | -17.91% |
| 2016 FY | 16.23 Million USD | -37.59% |
| 2016 Q4 | 3.28 Million USD | -25.69% |
| 2016 Q1 | 4.55 Million USD | -28.31% |
| 2016 Q3 | 4.41 Million USD | 10.95% |
| 2016 Q2 | 3.98 Million USD | -12.58% |
| 2015 FY | 26.01 Million USD | -0.25% |
| 2015 Q2 | 6.33 Million USD | -10.1% |
| 2015 Q3 | 6.27 Million USD | -1.04% |
| 2015 Q4 | 6.35 Million USD | 1.29% |
| 2015 Q1 | 7.05 Million USD | 3.19% |
| 2014 Q3 | 6.16 Million USD | -7.32% |
| 2014 Q2 | 6.65 Million USD | 3.61% |
| 2014 FY | 26.08 Million USD | 13.75% |
| 2014 Q4 | 6.83 Million USD | 10.76% |
| 2014 Q1 | 6.42 Million USD | -8.16% |
| 2013 Q3 | 6.23 Million USD | 17.6% |
| 2013 Q4 | 6.99 Million USD | 12.23% |
| 2013 FY | 22.93 Million USD | 54.21% |
| 2013 Q2 | 5.3 Million USD | 20.4% |
| 2013 Q1 | 4.4 Million USD | 7.1% |
| 2012 Q3 | 3.29 Million USD | -1.76% |
| 2012 Q2 | 3.35 Million USD | -18.27% |
| 2012 Q4 | 4.11 Million USD | 24.66% |
| 2012 FY | 14.86 Million USD | -10.22% |
| 2012 Q1 | 4.1 Million USD | -23.54% |
| 2011 Q4 | 5.37 Million USD | 25.47% |
| 2011 FY | 16.56 Million USD | 150.2% |
| 2011 Q3 | 4.28 Million USD | 0.0% |
| 2010 FY | 6.61 Million USD | -3.54% |
| 2009 FY | 6.86 Million USD | -29.54% |
| 2008 FY | 9.73 Million USD | -22.21% |
| 2007 FY | 12.51 Million USD | 87.17% |
| 2006 FY | 6.68 Million USD | 60.22% |
| 2005 FY | 4.17 Million USD | 241.29% |
| 2004 FY | 1.22 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -101.47% |
| Cerus Corporation | 143.15 Million USD | 84.204% |
| OrthoPediatrics Corp. | 137.01 Million USD | 83.496% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -99.043% |
| Talis Biomedical Corporation | 67.18 Million USD | 66.343% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | 9.352% |
| Inogen, Inc. | 236.08 Million USD | 90.422% |
| Spectral AI, Inc. | 20.86 Million USD | -8.383% |
| Nano-X Imaging Ltd. | 55.99 Million USD | 59.617% |
| CVRx, Inc. | 76.14 Million USD | 70.302% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -540.959% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -81.063% |
| Orthofix Medical Inc. | 667.42 Million USD | 96.612% |
| Venus Concept Inc. | 80.47 Million USD | 71.901% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 60.032% |
| Bioventus Inc. | 409.91 Million USD | 94.484% |
| BrainsWay Ltd. | 28.01 Million USD | 19.291% |
| Envoy Medical, Inc. | 17.89 Million USD | -26.344% |
| electroCore, Inc. | 32.03 Million USD | 29.403% |
| IceCure Medical Ltd | 16.87 Million USD | -33.995% |
| Lucid Diagnostics Inc. | 42.43 Million USD | 46.708% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -28.242% |
| MaxCyte, Inc. | 84.84 Million USD | 73.348% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -82.19% |
| Nexalin Technology, Inc. | 5.78 Million USD | -291.137% |
| PAVmed Inc | 64.82 Million USD | 65.118% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | 55.728% |
| RxSight, Inc. | 103.85 Million USD | 78.225% |
| Sight Sciences, Inc. | 126.44 Million USD | 82.117% |
| SI-BONE, Inc. | 156.35 Million USD | 85.537% |
| TELA Bio, Inc. | 84.18 Million USD | 73.14% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 67.722% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 88.881% |
| LivaNova PLC | 843.54 Million USD | 97.319% |
| 908 Devices Inc. | 68.08 Million USD | 66.785% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 95.324% |
| Nemaura Medical Inc. | 7.13 Million USD | -216.762% |
| NeuroPace, Inc. | 75.29 Million USD | 69.968% |
| LENSAR, Inc. | 33.33 Million USD | 32.166% |
| Apyx Medical Corporation | 51.01 Million USD | 55.676% |
| Cutera, Inc. | 197.72 Million USD | 88.563% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | 8.749% |
| BioSig Technologies, Inc. | 28.53 Million USD | 20.74% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 88.19% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | 37.291% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 97.296% |
| Axonics, Inc. | 270.2 Million USD | 91.631% |
| Outset Medical, Inc. | 198.77 Million USD | 88.624% |
| IRIDEX Corporation | 31.81 Million USD | 28.921% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 87.452% |
| IRadimed Corporation | 30.12 Million USD | 24.931% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -165.038% |
| INVO Bioscience, Inc. | 7.85 Million USD | -187.943% |
| Telesis Bio, Inc. | 63.48 Million USD | 64.383% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 77.032% |
| Varex Imaging Corporation | 224.8 Million USD | 89.941% |
| Quipt Home Medical Corp. | 148.66 Million USD | 84.789% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -92.894% |
| Pulmonx Corporation | 112.68 Million USD | 79.933% |
| Dynatronics Corporation | 9.9 Million USD | -128.229% |
| Modular Medical, Inc. | 17.52 Million USD | -29.003% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -12.018% |
| Semler Scientific, Inc. | 38.94 Million USD | 41.935% |
| InMode Ltd. | 215.68 Million USD | 89.515% |
| Bruker Corporation | 1.07 Billion USD | 97.899% |
| Cytosorbents Corporation | 48.33 Million USD | 53.218% |
| DexCom, Inc. | 1.69 Billion USD | 98.663% |
| Align Technology, Inc. | 2.07 Billion USD | 98.911% |
| Viveve Medical, Inc. | 22.17 Million USD | -1.984% |
| ZimVie Inc. | 275.12 Million USD | 91.781% |
| Movano Inc. | 29.69 Million USD | 23.836% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 83.527% |
| Nexalin Technology, Inc. | 5.78 Million USD | -291.137% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -540.959% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 96.237% |
| Profound Medical Corp. | 33.6 Million USD | 32.706% |
| Insulet Corporation | 939.9 Million USD | 97.594% |
| enVVeno Medical Corporation | 25.23 Million USD | 10.401% |
| Surmodics, Inc. | 98.69 Million USD | 77.088% |
| iCAD, Inc. | 22.22 Million USD | -1.746% |
| Biotricity, Inc. | 17.18 Million USD | -31.589% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 94.929% |
| Aethlon Medical, Inc. | 12.27 Million USD | -84.182% |
| InspireMD, Inc. | 22.95 Million USD | 1.468% |
| PAVmed Inc. | 64.82 Million USD | 65.118% |
| BIOLASE, Inc. | 34.66 Million USD | 34.76% |
| Beyond Air, Inc. | 61.7 Million USD | 63.35% |
| FONAR Corporation | 28.6 Million USD | 20.947% |
| AxoGen, Inc. | 149.33 Million USD | 84.858% |
| Vivani Medical, Inc. | 26.96 Million USD | 16.139% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 87.231% |
| Inari Medical, Inc. | 448.59 Million USD | 94.959% |
| UFP Technologies, Inc. | 58.08 Million USD | 61.072% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -358.905% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -257.898% |
| Tenon Medical, Inc. | 16.96 Million USD | -33.269% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -205.87% |
| Co-Diagnostics, Inc. | 44.1 Million USD | 48.727% |
| AdaptHealth Corp. | 1.07 Billion USD | 97.902% |
| Sintx Technologies, Inc. | 15.2 Million USD | -48.76% |
| NanoVibronix, Inc. | 4.97 Million USD | -354.715% |
| Quanterix Corporation | 118.1 Million USD | 80.853% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -92.894% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -56.578% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 94.241% |
| TransMedics Group, Inc. | 182.82 Million USD | 87.631% |
| ReWalk Robotics Ltd. | 28.06 Million USD | 19.426% |
| NeuroMetrix, Inc. | 11.09 Million USD | -103.74% |
| Hyperfine, Inc. | 52.87 Million USD | 57.231% |
| Establishment Labs Holdings Inc. | 172 Million USD | 86.853% |
| Biomerica, Inc. | 6.97 Million USD | -224.061% |
| Bone Biologics Corporation | 9.42 Million USD | -139.842% |
| AVITA Medical, Inc. | 80.77 Million USD | 72.006% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -119.305% |
| Silk Road Medical, Inc | 186.35 Million USD | 87.866% |